Atlas Trials

A Randomized Placebo-controlled Phase 2 Study of Decitabine With or Without Eltrombopag in AML Patients

Clinical trial NCT02446145 · TERMINATED

Trial details

NCT number
NCT02446145
Sponsor
Technische Universität Dresden
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Acute Myeloid Leukemia
Start date
2015-05-01
Primary completion
2020-12-26
Enrollment
132

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.